The Oxford Covid-19 vaccine may be the first to obtain the Indian regulator DCGI Nod for emergency use
The Oxford Covid-19 vaccine could become the first to achieve India’s regulatory gesture for emergency use
A new study suggests that COVID-19 antibodies could protect against reinfection for at least 6 months
